|
Deep vein thrombosis
Citations 61-70 of 138 total displayed.
|
Past content
(since Apr 2001):
|
- Genetics
Polymorphism in the ß2-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk Determinants for Idiopathic Venous Thromboembolism: A Multilocus, Population-Based, Prospective Genetic Analysis
- Robert Y.L. Zee, Nancy R. Cook, Suzanne Cheng, Henry A. Erlich, Klaus Lindpaintner, and Paul M Ridker
Circulation 2006;113:2193-2200; published online before print as doi:10.1161/CIRCULATIONAHA.106.615401
[Abstract]
[Full text]
- Articles
Polymorphism in the 2-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk Determinants for Idiopathic Venous Thromboembolism. A Multilocus, Population-Based, Prospective Genetic Analysis
- Robert Y.L. Zee, Nancy R. Cook, Suzanne Cheng, Henry A. Erlich, Klaus Lindpaintner, and Paul M Ridker
Circulation published May 1, 2006, doi:10.1161/CIRCULATIONAHA.106.615401
[Abstract]
- Clinician Update
Anticoagulants and Transaminase Elevation
- Nipun Arora and Samuel Z. Goldhaber
Circulation 2006;113:e698-702e, doi:10.1161/CIRCULATIONAHA.105.603100
[Full text]
- Clinician Update
Venous Thromboembolism in Children
- Sudha Parasuraman and Samuel Z. Goldhaber
Circulation 2006;113:e12-16e, doi:10.1161/CIRCULATIONAHA.105.583773
[Full text]
- Vascular Medicine
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration
- Céline Straczek, Emmanuel Oger, Marianne Beau Yon de Jonage-Canonico, Geneviève Plu-Bureau, Jacqueline Conard, Guy Meyer, Martine Alhenc-Gelas, Hervé Lévesque, Nathalie Trillot, Marie-Thérèse Barrellier, Denis Wahl, Joseph Emmerich, Pierre-Yves Scarabin for the Estrogen and Thromboembolism Risk (ESTHER) Study Group
Circulation 2005;112:3495-3500; published online before print as doi:10.1161/CIRCULATIONAHA.105.565556
[Abstract]
[Full text]
- Articles
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women. Impact of the Route of Estrogen Administration
- Céline Straczek, Emmanuel Oger, Marianne Beau Yon de Jonage-Canonico, Geneviève Plu-Bureau, Jacqueline Conard, Guy Meyer, Martine Alhenc-Gelas, Hervé Lévesque, Nathalie Trillot, Marie-Thérèse Barrellier, Denis Wahl, Joseph Emmerich, Pierre-Yves Scarabin for the Estrogen and Thromboembolism Risk (ESTHER) Study Group
Circulation published November 21, 2005, doi:10.1161/CIRCULATIONAHA.105.565556
[Abstract]
- Vascular Medicine
High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men
- Hiroshi Deguchi, Natalie M. Pecheniuk, Darlene J. Elias, Patricia M. Averell, and John H. Griffin
Circulation 2005;112:893-899, doi:10.1161/CIRCULATIONAHA.104.521344
[Abstract]
[Full text]
- Cardiology Patient Pages
Antiphospholipid Antibodies
- Caron P. Misita and Stephan Moll
Circulation 2005;112:e39-44e, doi:10.1161/CIRCULATIONAHA.105.548495
[Full text]
- Editorials
Vena Cava Filters: Do We Know All That We Need to Know?
- Jack Ansell
Circulation 2005;112:298-299, doi:10.1161/CIRCULATIONAHA.105.547828
[Full text]
- Preventive Cardiology
Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prévention du Risque dEmbolie Pulmonaire par Interruption Cave) Randomized Study
- The PREPIC Study Group
Circulation 2005;112:416-422; published online before print as doi:10.1161/CIRCULATIONAHA.104.512834
[Abstract]
[Full text]
|
|